Cyclerion Therapeutics (CYCN) Return on Assets (2019 - 2025)
Historic Return on Assets for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to 0.42%.
- Cyclerion Therapeutics' Return on Assets fell 1000.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of 0.47% for FY2023, which is 11300.0% up from last year.
- According to the latest figures from Q3 2025, Cyclerion Therapeutics' Return on Assets is 0.42%, which was down 1000.0% from 0.33% recorded in Q2 2025.
- In the past 5 years, Cyclerion Therapeutics' Return on Assets registered a high of 0.98% during Q2 2024, and its lowest value of 1.99% during Q1 2023.
- In the last 5 years, Cyclerion Therapeutics' Return on Assets had a median value of 0.69% in 2021 and averaged 0.66%.
- Its Return on Assets has fluctuated over the past 5 years, first soared by 28600bps in 2024, then tumbled by -13000bps in 2025.
- Cyclerion Therapeutics' Return on Assets (Quarter) stood at 0.87% in 2021, then crashed by -89bps to 1.64% in 2022, then skyrocketed by 109bps to 0.15% in 2023, then tumbled by -312bps to 0.33% in 2024, then decreased by -29bps to 0.42% in 2025.
- Its Return on Assets was 0.42% in Q3 2025, compared to 0.33% in Q2 2025 and 0.29% in Q1 2025.